Rafael Holdings, Inc. (NYSE:RFL) Short Interest Up 30.1% in December

Rafael Holdings, Inc. (NYSE:RFLGet Free Report) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totaling 52,381 shares, an increase of 30.1% from the December 15th total of 40,257 shares. Currently, 0.2% of the company’s stock are short sold. Based on an average daily volume of 171,579 shares, the short-interest ratio is presently 0.3 days. Based on an average daily volume of 171,579 shares, the short-interest ratio is presently 0.3 days. Currently, 0.2% of the company’s stock are short sold.

Rafael Trading Up 0.8%

NYSE:RFL traded up $0.01 during midday trading on Friday, hitting $1.25. 41,107 shares of the company were exchanged, compared to its average volume of 120,066. Rafael has a fifty-two week low of $1.12 and a fifty-two week high of $3.19. The company has a market capitalization of $64.71 million, a PE ratio of -1.47 and a beta of 0.67. The company has a fifty day simple moving average of $1.26 and a 200 day simple moving average of $1.47.

Rafael (NYSE:RFLGet Free Report) last released its quarterly earnings data on Wednesday, October 29th. The company reported ($0.28) earnings per share (EPS) for the quarter. Rafael had a negative net margin of 3,044.70% and a negative return on equity of 32.82%. The company had revenue of $0.89 million during the quarter.

Institutional Investors Weigh In On Rafael

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Citadel Advisors LLC boosted its holdings in shares of Rafael by 132.3% in the third quarter. Citadel Advisors LLC now owns 72,584 shares of the company’s stock valued at $99,000 after acquiring an additional 41,335 shares during the period. Vanguard Group Inc. raised its position in Rafael by 10.5% in the 3rd quarter. Vanguard Group Inc. now owns 1,394,726 shares of the company’s stock valued at $1,897,000 after purchasing an additional 133,024 shares during the last quarter. Cable Car Capital LP purchased a new stake in Rafael in the 2nd quarter valued at $173,000. Marshall Wace LLP acquired a new stake in Rafael during the 2nd quarter worth $50,000. Finally, Geode Capital Management LLC grew its position in Rafael by 72.9% during the 2nd quarter. Geode Capital Management LLC now owns 451,139 shares of the company’s stock worth $781,000 after purchasing an additional 190,179 shares during the last quarter. Hedge funds and other institutional investors own 11.30% of the company’s stock.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Rafael in a report on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

View Our Latest Research Report on Rafael

Rafael Company Profile

(Get Free Report)

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia.

See Also

Receive News & Ratings for Rafael Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rafael and related companies with MarketBeat.com's FREE daily email newsletter.